{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:35:29Z","timestamp":1790807729777,"version":"4.1.0"},"reference-count":121,"publisher":"Wiley","issue":"S403","license":[{"start":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T00:00:00Z","timestamp":1185494400000},"content-version":"vor","delay-in-days":2520,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>Zohar J, Westenberg HGM. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000: 101: 39\u201349. \u00a9 Munksgaard 2000.<\/jats:p><jats:p>Objective: Anxiety disorders are the most common mental health disorders. While the older tricylic antidepressants (TCAs) are efficacious in the treatment of many anxiety disorders, recent studies with fluoxetine and other selective serotonin reuptake inhibitors (SSRIs) have emphasized the role of serotonin in the aetiology of these conditions.<\/jats:p><jats:p>Method: We reviewed the efficacy, safety and tolerability of TCAs and SSRIs in the treatment of the most common anxiety disorders, specifically, panic disorder, obsessive\u2010compulsive disorder, post\u2010traumatic stress disorder, social phobia and generalized anxiety disorder.<\/jats:p><jats:p>Results: Both the TCA and SSRI antidepressants are effective in treating a wide variety of anxiety disorders. SSRIs, due to their greater safety and tolerability, should be the preferred choices in treating anxiety disorders in those instances where TCAs and SSRIs are considered equally effective. In the cases of OCD and social phobia, SSRIs are almost always preferable given that the TCAs do not appear effective in these disorders.<\/jats:p><jats:p>Conclusion: Further research is needed on the naturalistic long\u2010term use of the TCAs and SSRIs in the treatment of anxiety disorders.<\/jats:p>","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T13:28:56Z","timestamp":1185542936000},"page":"39-49","source":"Crossref","is-referenced-by-count":155,"title":["Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors"],"prefix":"10.1111","volume":"101","author":[{"given":"J.","family":"Zohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G. M.","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800350011002"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01066762"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.151.5.873"},{"issue":"6","key":"e_1_2_1_5_2","first-page":"5","article-title":"Serotonin receptor specificity in anxiety disorders","volume":"57","author":"Lucki I.","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00139-5"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818060-00003"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110026004"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.6.766"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810210013002"},{"key":"e_1_2_1_11_2","first-page":"4","article-title":"High\u2010potency benzodiazepines for short\u2010term management of panic disorder: the US. experience","volume":"51","author":"Tesar GE.","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.11.1556"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198807000-00006"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290053007"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(93)90021-S"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021803"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(96)00043-2"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80375-1"},{"issue":"6","key":"e_1_2_1_19_2","first-page":"22","article-title":"Anxiety symptom relief in depression treatment outcomes","volume":"56","author":"Keller MB","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"e_1_2_1_20_2","first-page":"S45","article-title":"Treating comorbid depression and anxiety","volume":"43","author":"Kuzel RJ","year":"1996","journal-title":"J Fam Pract"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.1996.08.56"},{"issue":"8","key":"e_1_2_1_22_2","first-page":"11","article-title":"Management of patients with depression associated with anxiety symptoms","volume":"58","author":"Nutt D.","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_23_2","first-page":"455","article-title":"Antidepressant withdrawal reactions","volume":"56","author":"Wolfe RM.","year":"1997","journal-title":"Am Fam Physician"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.11.1570"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198701000-00002"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245749"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130046008"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.167.3.374"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.36"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(95)90629-R"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.6.549"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.173.1.54"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.9.1189"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050201"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199503000-00006"},{"issue":"10","key":"e_1_2_1_36_2","first-page":"51","article-title":"The role of SSRIs in panic disorder","volume":"57","author":"Sheehan DV","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812001-00002"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800360042006"},{"key":"e_1_2_1_39_2","first-page":"119","article-title":"Use of monochlorimipramine in psychiatric patients who are resistant to other therapy in Spanish","volume":"26","author":"Fernandez CE","year":"1967","journal-title":"Actas Luso-Espanol Neurol Psiquiatr"},{"key":"e_1_2_1_40_2","first-page":"111","article-title":"The action of chlorimipramine in obsessive\u2010compulsive neurosis: a pilot study","volume":"17","author":"Yaryura\u2010Tobias JA","year":"1975","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_41_2","first-page":"36","article-title":"Preliminary results from a multicenter trial of clomipramine in obsessive\u2010compulsive disorder","volume":"25","author":"Deveaugh\u2010geiss J","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780240079009"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790330057007"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0364-7722(81)90077-1"},{"key":"e_1_2_1_45_2","first-page":"8","article-title":"Imipramine and placebo in the treatment of obsessive\u2010compulsives: their effect on depression and on obsessional symptoms","volume":"23","author":"Foa EB","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_46_2","first-page":"193","article-title":"Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double\u2010blind crossover comparison","volume":"24","author":"Leonard H","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(87)90199-5"},{"key":"e_1_2_1_48_2","first-page":"119","article-title":"The relationship of plasma clomipramine and N\u2010desmethylclomipramine to response in obsessive\u2010compulsive disorder","volume":"26","author":"Mavissakalian M","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.7.909"},{"key":"e_1_2_1_50_2","first-page":"423","article-title":"Fluoxetine treatment of obsessive\u2010compulsive disorder: an open clinical trial","volume":"9","author":"Liebowitz MR","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(93)90266-O"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950070051010"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810010038006"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950160039008"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.468"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810180077011"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1998)8:1 <105::AID-DA16>3.0.CO;2-T"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.64.4.660"},{"key":"e_1_2_1_59_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/S0007125000297912","article-title":"Pharmacotherapy for obsessive\u2010compulsive disorder","volume":"35","author":"Greist JH","year":"1998","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(93)90030-K"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199403000-00006"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712243172604"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950240066012"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-1816.1990.tb01511.x"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(93)90004-C"},{"issue":"9","key":"e_1_2_1_66_2","first-page":"16","article-title":"The psychobiology of posttraumatic stress disorder","volume":"58","author":"Kolk BA.","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810150059010"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.4.513"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.10.1289"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199106000-00011"},{"key":"e_1_2_1_71_2","first-page":"325","article-title":"An open trial of fluoxetine in the treatment of posttraumatic stress disorder","volume":"11","author":"McDougle CJ","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199304000-00004"},{"key":"e_1_2_1_73_2","first-page":"517","article-title":"Fluoxetine in posttraumatic stress disorder","volume":"55","author":"Kolk BA","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.1.17"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/jts.2490090414"},{"key":"e_1_2_1_76_2","first-page":"502","article-title":"Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence","volume":"56","author":"Brady KT","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199802000-00003"},{"key":"e_1_2_1_78_2","first-page":"1569","article-title":"Post traumatic stress disorder","volume":"25","author":"Tiller J","year":"1996","journal-title":"Aust Fam Physician"},{"issue":"18","key":"e_1_2_1_79_2","first-page":"33","article-title":"Management of posttraumatic stress disorder; diagnostic and therapeutic issues","volume":"60","author":"Davidson JR","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"e_1_2_1_81_2","first-page":"91","article-title":"Identification of cases of anxiety disorders and affective disorders in the community according to ICD\u201010 and DSM\u2010III\u2010R by using the composite International Diagnostic Interview (CIDI)","volume":"2","author":"Wacker HR","year":"1992","journal-title":"Int J Meth Psychiatr Res"},{"issue":"17","key":"e_1_2_1_82_2","first-page":"20","article-title":"The nature of social anxiety disorder","volume":"59","author":"Westenberg HG.","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_83_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"1994"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700046419"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674377301800106"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.131.5.486"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.3.353"},{"key":"e_1_2_1_88_2","first-page":"71","article-title":"The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double\u2010blind, placebo\u2010controlled clinical study","volume":"247","author":"Anonymous.","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00002"},{"key":"e_1_2_1_90_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpsyc.1992.01820040034004","article-title":"Social phobia. Comorbidity and morbidity in an epidemiologic sample","volume":"49","author":"Schneier FR","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(92)90032-4"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1995.tb09596.x"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00003"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810340070009"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00008"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.8.708"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606000-00005"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00093-7"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1103"},{"key":"e_1_2_1_100_2","first-page":"27","article-title":"Fluoxetine efficacy in social phobia","volume":"101","author":"Ameringen M","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0405"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(94)90118-X"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00182-1"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244762"},{"key":"e_1_2_1_105_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.156.5.756","article-title":"Fluvoxamine treatment of social phobia: a double\u2010blind, placebo\u2010controlled study","volume":"156","author":"Stein MB","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1103"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.4.600"},{"issue":"7","key":"e_1_2_1_108_2","first-page":"9","article-title":"The long\u2010term management of generalized anxiety disorder: issues and dilemmas","volume":"57","author":"Schweizer E","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_1_109_2","first-page":"27","article-title":"Strategies for treatment of generalized anxiety in the primary care setting. (Review)","volume":"58","author":"Schweizer E","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"e_1_2_1_110_2","first-page":"31","article-title":"Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone","volume":"51","author":"Petracca A","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_111_2","first-page":"293","article-title":"Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms","volume":"49","author":"Hoehn\u2010Saric R","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820230054005"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800010081010"},{"key":"e_1_2_1_114_2","first-page":"214","article-title":"Clomipramine treatment for generalized anxiety disorder (letter)","volume":"12","author":"Wincerson D","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_115_2","first-page":"165","article-title":"Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder","volume":"34","author":"Allgulander C","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09660.x"},{"key":"e_1_2_1_117_2","first-page":"50","article-title":"Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features","volume":"55","author":"Tollefson GD","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300840-00013"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0202"},{"key":"e_1_2_1_120_2","first-page":"217","article-title":"Major agitated\u2010anxious versus blunted\u2010retarded depression: differential effects of fluoxetine in French","volume":"21","author":"Dalery J","year":"1995","journal-title":"Encephale"},{"key":"e_1_2_1_121_2","unstructured":"ACuiarLM HaskinsT RudolphRLet al.Double\u2010blind placebo\u2010controlled study of once\u2010daily venlafaxine extended release in outpatients with GAD (abstract). Annual Meeting of the American Psychiatric Association Toronto Canada1998(abstract NR643)."},{"key":"e_1_2_1_122_2","unstructured":"EntsuahR DerivanAT HaskinsTet al.Double\u2010blind placebo\u2010controlled study of once daily venlafaxine extended release and buspirone in outpatients with GAD (abstract). Annual Meeting of the American Psychiatric Association Toronto Canada1998(abstract NR644)."}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2000.tb10947.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2000.tb10947.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:48:27Z","timestamp":1695768507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2000.tb10947.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":121,"journal-issue":{"issue":"S403","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1111\/j.1600-0447.2000.tb10947.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2000.tb10947.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}